Skip to main content
. 2018 Aug;13(4):343–352. doi: 10.4103/1735-5362.235161

Fig. 2.

Fig. 2

Effects of thalidomide on the viability of 3T3 fibroblast cells and human umbilical vein endothelial cells (HUVECs). The cells were treated for 24 h with various concentrations of thalidomide and the percentage of viable cells was measured by MTT assay. Data are presented as mean ± SEM (n = 6).